$PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.

2016 Q1 Form 10-K Financial Statement

#000119312516523701 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.100M $5.820M $13.27M
YoY Change 181.11% 117.16% 20.65%
% of Gross Profit
Research & Development $2.408M $3.670M $11.38M
YoY Change -1.65% 130.82% 95.9%
% of Gross Profit
Depreciation & Amortization $3.496K $170.0K $13.17K
YoY Change 9.63% 0.0% 54.3%
% of Gross Profit
Operating Expenses $8.507M $9.663M $11.38M
YoY Change 84.13% 117.49% 95.9%
Operating Profit -$8.507M -$24.65M
YoY Change 84.12% 95.15%
Interest Expense $0.00 $10.00K $151.4K
YoY Change -100.0% -99.07% -93.66%
% of Operating Profit
Other Income/Expense, Net $1.000K $11.00K
YoY Change -98.95% -98.98%
Pretax Income -$8.510M -$9.650M -$24.50M
YoY Change 87.86% -1276.83% 139.21%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$8.506M -$9.652M -$24.50M
YoY Change 87.98% -1282.84% 139.21%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$41.46K -$47.11K -$125.2K
COMMON SHARES
Basic Shares Outstanding 205.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.760M $14.18M $14.18M
YoY Change -31.12% -18.46% -18.47%
Cash & Equivalents $9.761M $14.18M $14.18M
Short-Term Investments
Other Short-Term Assets $336.9K $41.19K $41.19K
YoY Change -72.47% -95.79% -95.79%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.45M $14.72M $14.72M
YoY Change -34.13% -22.94% -22.94%
LONG-TERM ASSETS
Property, Plant & Equipment $81.65K $85.15K $85.15K
YoY Change -8.24% -7.62% -7.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.00K $27.00K $27.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $5.571M $5.720M $5.720M
YoY Change -19.38% -19.23% -19.23%
TOTAL ASSETS
Total Short-Term Assets $10.45M $14.72M $14.72M
Total Long-Term Assets $5.571M $5.720M $5.720M
Total Assets $16.02M $20.44M $20.44M
YoY Change -29.65% -21.94% -21.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.400M $1.890M $1.887M
YoY Change 115.38% 329.55% 328.22%
Accrued Expenses $440.0K $2.240M $2.236M
YoY Change 18.92% 446.34% 449.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.835M $4.123M $4.123M
YoY Change 79.44% 386.35% 386.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.835M $4.123M $4.123M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.830M $4.123M $4.123M
YoY Change 70.24% 314.66% 314.66%
SHAREHOLDERS EQUITY
Retained Earnings -$189.3M -$180.8M
YoY Change 17.71% 15.68%
Common Stock $212.8K $205.0K
YoY Change 14.44% 10.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.18M $16.32M $16.32M
YoY Change
Total Liabilities & Shareholders Equity $16.02M $20.44M $20.44M
YoY Change -29.65% -21.94% -21.94%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$8.506M -$9.652M -$24.50M
YoY Change 87.98% -1282.84% 139.21%
Depreciation, Depletion And Amortization $3.496K $170.0K $13.17K
YoY Change 9.63% 0.0% 54.3%
Cash From Operating Activities -$8.050M -$4.960M -$17.41M
YoY Change 92.12% 18.66% 25.73%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $6.139K
YoY Change -91.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$6.140K
YoY Change -91.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.640M 260.0K 14.20M
YoY Change 275.26% -93.14% -9.03%
NET CHANGE
Cash From Operating Activities -8.050M -4.960M -17.41M
Cash From Investing Activities 0.000 -6.140K
Cash From Financing Activities 3.640M 260.0K 14.20M
Net Change In Cash -4.410M -4.700M -3.213M
YoY Change 36.96% 1105.13% 4451.21%
FREE CASH FLOW
Cash From Operating Activities -$8.050M -$4.960M -$17.41M
Capital Expenditures $0.00 $6.139K
Free Cash Flow -$4.960M -$17.42M
YoY Change 18.66% 25.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 pvct Common Stock Shares Issued In Lieu Of Cash Dividend
CommonStockSharesIssuedInLieuOfCashDividend
61022 shares
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q1 pvct Securities Purchase Agreement Price Per Unit
SecuritiesPurchaseAgreementPricePerUnit
0.75
CY2013Q1 pvct Convertible Preferred Stock Par Value Per Share Securities Purchase Agreement
ConvertiblePreferredStockParValuePerShareSecuritiesPurchaseAgreement
0.001
CY2013Q1 pvct Common Stock Unit Fair Value Of Warrants Recorded On Issuance
CommonStockUnitFairValueOfWarrantsRecordedOnIssuance
1297950
CY2013Q1 pvct Common Stock Unit Beneficial Conversion Amount
CommonStockUnitBeneficialConversionAmount
1025950
CY2013Q3 pvct Common Stock Shares Issued In Lieu Of Cash Dividend
CommonStockSharesIssuedInLieuOfCashDividend
34598 shares
CY2013Q4 pvct Common Stock Shares Issued In Lieu Of Cash Dividend
CommonStockSharesIssuedInLieuOfCashDividend
12066 shares
CY2014Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
33334 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
59861601 shares
CY2015Q4 pvct Class Of Warrant Or Right Discounted Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightDiscountedExercisePriceOfWarrantsOrRights
0.50
CY2015Q4 pvct Class Of Warrant Or Right Cash Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCashExercisePriceOfWarrantsOrRights
0.85
CY2013Q2 us-gaap Litigation Reserve
LitigationReserve
100000
CY2013Q2 pvct Common Stock Shares Issued In Lieu Of Cash Dividend
CommonStockSharesIssuedInLieuOfCashDividend
29384 shares
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
205030845 shares
CY2014Q2 us-gaap Loss Contingency Receivable
LossContingencyReceivable
2240000
CY2014Q2 pvct Reimbursement Receivable Percentage
ReimbursementReceivablePercentage
0.25 pure
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2013Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
441667 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3036218 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.00
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
372000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.25
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.25
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.25
CY2015Q2 dei Entity Public Float
EntityPublicFloat
105469044
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
4393484
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1221701
CY2012Q4 pvct Revised Exercise Price Of Warrants Due To New Issuance Price
RevisedExercisePriceOfWarrantsDueToNewIssuancePrice
0.675
CY2013Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
2925000 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2013Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3899840 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6628666
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15696243
CY2013Q4 pvct Number Of Non Employee To Whom Consulting Services Paid
NumberOfNonEmployeeToWhomConsultingServicesPaid
1 NonEmployee
CY2014Q1 pvct Convertible Preferred Stock Share Outstanding
ConvertiblePreferredStockShareOutstanding
0 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.25
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
184796275 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
184796275 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
315738
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
25189876
CY2014Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
440702
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
91282
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181298890
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8131737
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156293810
CY2014Q4 us-gaap Liabilities
Liabilities
994282
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26184158
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
184796
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
437863
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
847722
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
44431000
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1380000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34046000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
45811000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2014Q4 us-gaap Assets
Assets
26184158
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
6344000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92171
CY2014Q4 us-gaap Assets Current
AssetsCurrent
19102934
CY2014Q4 us-gaap Loss Contingency Receivable Current
LossContingencyReceivableCurrent
733333
CY2014Q4 us-gaap Loss Contingency Receivable Noncurrent
LossContingencyReceivableNoncurrent
3378345
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
978000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3583708
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17391601
CY2014Q4 pvct Deferred Tax Assets Warrants For Services
DeferredTaxAssetsWarrantsForServices
5421000
CY2014Q4 pvct Uncertain Tax Positions
UncertainTaxPositions
0
CY2014Q4 pvct Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
3200000
CY2014Q4 pvct Warrant Liability
WarrantLiability
146560
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10630000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0 shares
CY2015Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.96
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
204979100 shares
CY2015Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.96
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
10630000 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10630000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
204979100 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
252418
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
16316941
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1887171
CY2015Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1850000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133282
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
196908112
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8802857
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180796150
CY2015Q4 us-gaap Liabilities
Liabilities
4122871
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20439812
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
204979
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
451028
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4122871
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54534000
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1121000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Litigation Reserve
LitigationReserve
227750
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42457000
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55655000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2015Q4 us-gaap Assets
Assets
20439812
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
6602000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85145
CY2015Q4 us-gaap Assets Current
AssetsCurrent
14720094
CY2015Q4 us-gaap Loss Contingency Receivable Current
LossContingencyReceivableCurrent
500000
CY2015Q4 us-gaap Loss Contingency Receivable Noncurrent
LossContingencyReceivableNoncurrent
2011735
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
41192
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
110000000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2912588
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14178902
CY2015Q4 pvct Deferred Tax Assets Warrants For Services
DeferredTaxAssetsWarrantsForServices
5633000
CY2015Q4 pvct Uncertain Tax Positions
UncertainTaxPositions
0
CY2015Q4 pvct Reduced Amount Of Deferred Tax Asset
ReducedAmountOfDeferredTaxAsset
0
CY2015Q4 pvct Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding And Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingAndExercisableOptions
80121595 shares
CY2015Q4 pvct Number Of Shares Issuable On Exercises Of Warrants Issued
NumberOfSharesIssuableOnExercisesOfWarrantsIssued
59861601 shares
CY2015Q4 pvct Litigation Settlement Remaining Balance Due
LitigationSettlementRemainingBalanceDue
2511735
CY2015Q4 pvct Long Term Receivable Reimbursable Legal Fees
LongTermReceivableReimbursableLegalFees
683250
CY2015Q4 pvct Litigation Settlement Remaining Reserve
LitigationSettlementRemainingReserve
870578
CY2015Q4 pvct Deferred Tax Assets Theft Loss
DeferredTaxAssetsTheftLoss
963000
CY2013Q1 pvct Units Issued During Period Value Securities Purchase Agreement
UnitsIssuedDuringPeriodValueSecuritiesPurchaseAgreement
2550000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
400000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Number Of Employees Affected
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected
2 Employees
CY2015Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.75
CY2015Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1600000 shares
CY2013Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08 pure
CY2013Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
29063
CY2013Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
21921
CY2013Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
50860
CY2013Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
28104
CY2013Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10586
CY2014Q4 pvct Share Based Compensation Arrangement By Share Based Payment Award Options Settlements In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSettlementsInPeriod
2800000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
300000 shares
CY2014Q2 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
1120000
CY2014Q2 pvct Annual Cash Bonus Percentage
AnnualCashBonusPercentage
0.70 pure
CY2014Q2 pvct Future Payments Ratio Of Contingent Consideration
FuturePaymentsRatioOfContingentConsideration
2 pure
CY2014Q3 pvct Attorneys Fees Awarded By Court In Legal Settlement
AttorneysFeesAwardedByCourtInLegalSettlement
911000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000 shares
CY2013Q4 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
54000
CY2014Q1 pvct Convertible Preferred Stock Shares To Be Converted To Common Stock Shares
ConvertiblePreferredStockSharesToBeConvertedToCommonStockShares
33334 shares
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9892472
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0025 pure
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.00 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.181 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.045 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.57
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
132000796 shares
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6650
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-27697744
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28886392
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-13027939
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
526000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
1325
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
226000
CY2013 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1188648
CY2013 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
29063
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
14671130
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
55379
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14474542
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5015000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6650
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
24373664
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3595555
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-103912
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
142310
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
142310
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
105434
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8761264
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1786824
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9417000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
671120
CY2013 us-gaap Depreciation
Depreciation
6366
CY2013 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1246000
CY2013 pvct Net Proceeds From Sales Of Preferred Stock And Warrants
NetProceedsFromSalesOfPreferredStockAndWarrants
2550000
CY2013 pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
3433392
CY2013 pvct Cash Paid For Preferred Dividend
CashPaidForPreferredDividend
29063
CY2013 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-14671130
CY2013 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
1786824
CY2013 pvct Loss On Change In Fair Value Of Warrant Liability
LossOnChangeInFairValueOfWarrantLiability
6911583
CY2013 pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
18419335
CY2013 pvct Amount Reclassified From Warrant Liability To Equity
AmountReclassifiedFromWarrantLiabilityToEquity
4402078
CY2013 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
7835470
CY2013 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
142310
CY2013 pvct Effective Income Tax Rate Reconciliation Gain On Warrant Liability
EffectiveIncomeTaxRateReconciliationGainOnWarrantLiability
0.204 pure
CY2013 pvct Preferred Stock Issued During Period Pursuant To Regulation Of Value
PreferredStockIssuedDuringPeriodPursuantToRegulationOfValue
1252050
CY2013 pvct Income Tax Reconciliation Gain Loss On Warrant Liability
IncomeTaxReconciliationGainLossOnWarrantLiability
-5648000
CY2013 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
3873187
CY2013 pvct Issuance Of Stock For Services
IssuanceOfStockForServices
526000
CY2013 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
18419335
CY2013 pvct Advances To Travel Expenses
AdvancesToTravelExpenses
752034
CY2013 pvct Travel Expenses Not Authentic
TravelExpensesNotAuthentic
54034
CY2013 pvct Advances To Travel Expenses Without Receipt
AdvancesToTravelExpensesWithoutReceipt
698000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13847411
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0025 pure
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2M12D
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.00 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.637 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.477 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.045 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0003 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.77
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0004 pure
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
175828004 shares
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70590
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-10242990
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10242990
CY2014 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
4178345
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-12663028
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
978000
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
418250
CY2014 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-66667
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
5645
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
320000
CY2014 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2384393
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
60000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1695358
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4862000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-70590
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15613359
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5137927
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
242943
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
115645
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
115645
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
91833
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11002326
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2321327
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3483000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1327300
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
671120
CY2014 us-gaap Depreciation
Depreciation
8532
CY2014 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-461000
CY2014 pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
4490757
CY2014 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
2384393
CY2014 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
2321327
CY2014 pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
11122602
CY2014 pvct Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Probability Rate
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsProbabilityRate
0.05 pure
CY2014 pvct Amount Reclassified From Warrant Liability To Equity
AmountReclassifiedFromWarrantLiabilityToEquity
10335619
CY2014 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
4490757
CY2014 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
115645
CY2014 pvct Effective Income Tax Rate Reconciliation Gain On Warrant Liability
EffectiveIncomeTaxRateReconciliationGainOnWarrantLiability
-0.092 pure
CY2014 pvct Income Tax Reconciliation Gain Loss On Warrant Liability
IncomeTaxReconciliationGainLossOnWarrantLiability
918000
CY2014 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
959320
CY2014 pvct Issuance Of Stock For Services
IssuanceOfStockForServices
418250
CY2014 pvct Reclassification Of Adjusted Fair Value Of Warrants Into Additional Paid In Capital
ReclassificationOfAdjustedFairValueOfWarrantsIntoAdditionalPaidInCapital
2377133
CY2014 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
11122602
CY2014 pvct Advances To Travel Expenses
AdvancesToTravelExpenses
819000
CY2014 pvct Advances To Travel Expenses Without Receipt
AdvancesToTravelExpensesWithoutReceipt
0
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17410217
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0025 pure
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000315545
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.00 pure
CY2015 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y11M1D
CY2015 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company completed a Section 382 study for the perio d from inception through the year ended December 31, 2014 and recorded a limitation of $3.2 million to their net operating loss carry-forward.
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.387 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.045 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.38
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1750000 shares
CY2015 dei Entity Registrant Name
EntityRegistrantName
PROVECTUS BIOPHARMACEUTICALS, INC.
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1750000 shares
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.38
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <u>Estimates</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2015 us-gaap Lessor Leasing Arrangements Operating Leases Renewal Term
LessorLeasingArrangementsOperatingLeasesRenewalTerm
P1Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6139
CY2015 dei Trading Symbol
TradingSymbol
PVCT
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
195661859 shares
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00 pure
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-24502340
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24502340
CY2015 us-gaap Revenues
Revenues
0
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12099150
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-24653761
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-253558
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
202814
CY2015 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1599943
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
4861
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
212000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-146560
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
60000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3212699
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9490000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6139
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14203657
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10708569
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21320
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
670576
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
670576
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1446469
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13274072
CY2015 pvct Litigation Settlement Present Value Of Discount Remaining
LitigationSettlementPresentValueOfDiscountRemaining
197686
CY2015 pvct Increase Decrease In Accrued Settlement Expenses
IncreaseDecreaseInAccruedSettlementExpenses
1850000
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
552358
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8331000
CY2015 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16151
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
671120
CY2015 us-gaap Salaries And Wages
SalariesAndWages
500000
CY2015 us-gaap Depreciation
Depreciation
13165
CY2015 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1103000
CY2015 pvct Proceeds From Exercises Of Warrants And Stock Options
ProceedsFromExercisesOfWarrantsAndStockOptions
549730
CY2015 pvct Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
146560
CY2015 pvct Warrant Issued During Period For Services Value
WarrantIssuedDuringPeriodForServicesValue
552358
CY2015 pvct Net Proceeds From Sales Of Common Stock And Warrants
NetProceedsFromSalesOfCommonStockAndWarrants
13653927
CY2015 pvct Cash And Cash Equivalents Maximum Investments Maturity Period
CashAndCashEquivalentsMaximumInvestmentsMaturityPeriod
Three months or less
CY2015 pvct Stock Issued During Period Warrants And Stock Options Exercised Value
StockIssuedDuringPeriodWarrantsAndStockOptionsExercisedValue
549730
CY2015 pvct Adjustments To Additional Paid In Capital Employee Compensation From Stock Options Value
AdjustmentsToAdditionalPaidInCapitalEmployeeCompensationFromStockOptionsValue
670576
CY2015 pvct Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding And Exercisable Options Weighted Average Remaining Contractual Term
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm
P3Y29D
CY2015 pvct Effective Income Tax Rate Reconciliation Gain On Warrant Liability
EffectiveIncomeTaxRateReconciliationGainOnWarrantLiability
-0.002 pure
CY2015 pvct Number Of Long Term Incentive Compensation Plans
NumberOfLongTermIncentiveCompensationPlans
Two
CY2015 pvct Income Tax Reconciliation Gain Loss On Warrant Liability
IncomeTaxReconciliationGainLossOnWarrantLiability
56000
CY2015 pvct Employment Agreement Period For Executive
EmploymentAgreementPeriodForExecutive
P5Y
CY2015 pvct Gain Loss On Revaluation Of Warrants Liability
GainLossOnRevaluationOfWarrantsLiability
66809
CY2015 pvct Litigation Settlement Payment Description
LitigationSettlementPaymentDescription
The remaining cash settlement amounts will continue to be repaid to the Company over a period of four years with the second payment due in total by October 2016 and the final payment is expected to be received by October 3, 2019. $103,969 of the settlement discount was amortized as of December 31, 2015.
CY2015 pvct Issuance Of Stock For Services
IssuanceOfStockForServices
202814
CY2015 pvct Portion Of Insurance Coverage
PortionOfInsuranceCoverage
250000
CY2015 pvct Automatic Employment Renewal Period For Executive
AutomaticEmploymentRenewalPeriodForExecutive
P1Y
CY2015 pvct Minimum Percentage Required To Recognized Uncertain Income Tax Position
MinimumPercentageRequiredToRecognizedUncertainIncomeTaxPosition
0.50 pure
CY2015 pvct Issuance Of Common Stock And Warrants Pursuant To Regulation D Value
IssuanceOfCommonStockAndWarrantsPursuantToRegulationDValue
1554777
CY2015 pvct Litigation Settlement Amortization Of Discount
LitigationSettlementAmortizationOfDiscount
103969
CY2015 pvct Advances To Travel Expenses
AdvancesToTravelExpenses
898430
CY2015 pvct Advances To Travel Expenses With Receipt
AdvancesToTravelExpensesWithReceipt
297170
CY2013Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
409640
CY2013Q1 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
4045510
CY2013Q1 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
CY2013Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
859833 shares
CY2013Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1924973 shares
CY2013Q1 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
5394013 shares
CY2014Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
168860000 shares
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-6667000
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6667000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2285000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
4382000
CY2014Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
900317
CY2014Q1 pvct Aggregate Exercise Price Of Warrants Exercised
AggregateExercisePriceOfWarrantsExercised
2672364
CY2014Q1 pvct Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
3036218 shares
CY2014Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
121500 shares
CY2014Q1 pvct Warrants Exercised On Cashless Basis
WarrantsExercisedOnCashlessBasis
12522198 shares
CY2014Q1 pvct Number Of Warrants Exercised
NumberOfWarrantsExercised
1756665 shares
CY2014Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
733000 shares
CY2014Q1 pvct Stock Issued During Period Shares Warrants Exercised On Cashless Basis
StockIssuedDuringPeriodSharesWarrantsExercisedOnCashlessBasis
9100824 shares
CY2015Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
185196000 shares
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.02
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-4525000
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4525000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
95000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
4620000
CY2015Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1632
CY2015Q1 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
776000
CY2015Q1 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
1.00
CY2015Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
3693898 shares
CY2015Q1 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
0.50 pure
CY2015Q1 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
3000 shares
CY2015Q1 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
776000 shares
CY2013Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
931655
CY2013Q2 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
2641501
CY2013Q2 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
CY2013Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1051500 shares
CY2013Q2 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
1.50 pure
CY2013Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
2605000 shares
CY2013Q2 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
3522001 shares
CY2014Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
175554000 shares
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-643000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-643000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3517000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
4160000
CY2014Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
450002
CY2014Q2 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
5000000
CY2014Q2 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
2.50
CY2014Q2 pvct Aggregate Exercise Price Of Warrants Exercised
AggregateExercisePriceOfWarrantsExercised
372000
CY2014Q2 pvct Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
372000 shares
CY2014Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
315000 shares
CY2014Q2 pvct Warrants Exercised On Cashless Basis
WarrantsExercisedOnCashlessBasis
1594082 shares
CY2014Q2 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
1.00 pure
CY2014Q2 pvct Number Of Warrants Exercised
NumberOfWarrantsExercised
133232 shares
CY2014Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
202000 shares
CY2014Q2 pvct Stock Issued During Period Shares Warrants Exercised On Cashless Basis
StockIssuedDuringPeriodSharesWarrantsExercisedOnCashlessBasis
915467 shares
CY2014Q2 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
2000000 shares
CY2015Q2 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
187793000 shares
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.02
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-4545000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4545000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
4592000
CY2015Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
53582
CY2015Q2 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
1011100
CY2015Q2 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
1.00
CY2015Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1161790 shares
CY2015Q2 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
0.50 pure
CY2015Q2 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
100000 shares
CY2015Q2 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
1011100 shares
CY2013Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2013Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
186223
CY2013Q3 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
4613037
CY2013Q3 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
CY2013Q3 pvct Convertible Preferred Stock Shares To Be Converted To Common Stock Shares
ConvertiblePreferredStockSharesToBeConvertedToCommonStockShares
441667 shares
CY2013Q3 pvct Percentage Of Aggregate Shares Called By Warrant
PercentageOfAggregateSharesCalledByWarrant
0.10 pure
CY2013Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
136500 shares
CY2013Q3 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
1.50 pure
CY2013Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
442000 shares
CY2013Q3 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
6150718 shares
CY2014Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
179089000 shares
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.02
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3749000
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3749000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
3826000
CY2014Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4189
CY2014Q3 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
1.00
CY2014Q3 pvct Aggregate Amount Of Common Stock
AggregateAmountOfCommonStock
3586300
CY2014Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
228500 shares
CY2014Q3 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
0.50 pure
CY2014Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
6000 shares
CY2014Q3 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
3586300 shares
CY2015Q3 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
78877 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
204610000 shares
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.03
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-5780000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5780000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
5779000
CY2015Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
24262
CY2015Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1152135 shares
CY2015Q3 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
79500 shares
CY2013Q4 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
275000 shares
CY2013Q4 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
2400000
CY2013Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
259306
CY2013Q4 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
5820588
CY2013Q4 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
0.75
CY2013Q4 pvct Aggregate Exercise Price Of Warrants Exercised
AggregateExercisePriceOfWarrantsExercised
3412392
CY2013Q4 pvct Convertible Preferred Stock Shares To Be Converted To Common Stock Shares
ConvertiblePreferredStockSharesToBeConvertedToCommonStockShares
2925000 shares
CY2013Q4 pvct Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
3899840 shares
CY2013Q4 pvct Percentage Of Aggregate Shares Called By Warrant
PercentageOfAggregateSharesCalledByWarrant
0.10 pure
CY2013Q4 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
247973 shares
CY2013Q4 pvct Warrants Exercised On Cashless Basis
WarrantsExercisedOnCashlessBasis
4480005 shares
CY2013Q4 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
1.50 pure
CY2013Q4 pvct Number Of Warrants Exercised
NumberOfWarrantsExercised
1146662 shares
CY2013Q4 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
209473 shares
CY2013Q4 pvct Reclassification Of Adjusted Fair Value Of Warrants Into Additional Paid In Capital
ReclassificationOfAdjustedFairValueOfWarrantsIntoAdditionalPaidInCapital
765997
CY2013Q4 pvct Stock Issued During Period Shares Warrants Exercised On Cashless Basis
StockIssuedDuringPeriodSharesWarrantsExercisedOnCashlessBasis
2386004 shares
CY2013Q4 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
7760784 shares
CY2014Q4 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
75000 shares
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
182057000 shares
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
816000
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
816000
CY2014Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
4178000
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1081000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
4443000
CY2014Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
966819
CY2014Q4 pvct Gross Proceeds From Sales Of Common Stock And Warrants
GrossProceedsFromSalesOfCommonStockAndWarrants
4198300
CY2014Q4 pvct Purchase Price Of Common Stock With Warrants
PurchasePriceOfCommonStockWithWarrants
1.00
CY2014Q4 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
1027635 shares
CY2014Q4 pvct Percentage Of Common Shares Issuable On Exercise Of Each Warrant
PercentageOfCommonSharesIssuableOnExerciseOfEachWarrant
0.50 pure
CY2014Q4 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1503913 shares
CY2014Q4 pvct Stocks Issued During Period Shares Issued For Cash
StocksIssuedDuringPeriodSharesIssuedForCash
4198300 shares
CY2015Q4 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
76750 shares
CY2015Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
204735000 shares
CY2015Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.05
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-9652000
CY2015Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9652000
CY2015Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
9663000
CY2015Q4 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
472882
CY2015Q4 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Forfeited
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsForfeited
252500 shares
CY2015Q4 pvct Share Based Goods And Nonemployee Services Transaction Quantity Of Warrants Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfWarrantsIssued
1766202 shares

Files In Submission

Name View Source Status
0001193125-16-523701-index-headers.html Edgar Link pending
0001193125-16-523701-index.html Edgar Link pending
0001193125-16-523701.txt Edgar Link pending
0001193125-16-523701-xbrl.zip Edgar Link pending
d105545d10k.htm Edgar Link pending
d105545dex23.htm Edgar Link pending
d105545dex31.htm Edgar Link pending
d105545dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g105545tx_pg37.jpg Edgar Link pending
pvct-20151231.xml Edgar Link completed
pvct-20151231.xsd Edgar Link pending
pvct-20151231_cal.xml Edgar Link unprocessable
pvct-20151231_def.xml Edgar Link unprocessable
pvct-20151231_lab.xml Edgar Link unprocessable
pvct-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending